Financial Management Professionals’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-243
Closed -$14K – 1012
2023
Q1
$14K Hold
243
– – ﹤0.01% 500
2022
Q4
$15K Sell
243
-45,198
-99% -$2.72M ﹤0.01% 425
2022
Q3
$2.57M Buy
45,441
+30,561
+205% +$1.88M 0.59% 31
2022
Q2
$951K Buy
+14,880
New +$945K 0.23% 41

Other funds holding IHE

Financial Management Professionals's IHE Position: Q2 2023 in Review

Financial Management Professionals sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2023, closing a stake of 243 shares — an estimated $14K sold.

Financial Management Professionals first reported a position in IHE in Q2 2022 and held it in 4 quarters. The position peaked at $2.57M in Q3 2022. 118 funds tracked by Wall St. Rank hold IHE as of Q2 2023.

  • Financial Management Professionals reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2023 after selling out during the quarter.
  • Financial Management Professionals sold 243 iShares US Pharmaceuticals ETF shares in Q2 2023, an estimated $14K.
  • Financial Management Professionals first reported a position in iShares US Pharmaceuticals ETF in Q2 2022 and held it in 4 quarters.
  • Financial Management Professionals's iShares US Pharmaceuticals ETF position peaked at $2.57M in Q3 2022.
  • 118 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2023.

Based on Financial Management Professionals's 13F filing for Q2 2023, filed 10 Jul 2023.